Back to Results

Medwellai Inc (MWAI)

MedWellAI Inc. is a common stock listing on OTC Markets under the symbol MWAI. The company, based in Clearwater, Florida, operates through a subsidiary that develops, acquires, runs, and invests in businesses focused on AI-driven healthcare and wellness solutions. Its activities include a B2B e-commerce platform for distributing pharmaceutical products, with particular emphasis on GLP medications used in weight loss and diabetes management. MedWellAI also provides an AI-enabled ordering system designed to support healthcare providers such as wellness clinics, med spas, and corporate wellness facilities, with features that include inventory tracking and product suggestions. The company was formerly known as Integrated Ventures, Inc. and adopted its current name in June 2025.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-MWAI
$0.39
4.4% Upside
Fair
Not available
Not available
Fair
0.0%
September 25, 2026
1.3x
2.419 M
3.023 M
18.7%
51.8%
-475.6
18.3%
Valuation • Fair Value

Medwellai Inc (OTC-MWAI) Fair Value by Valuation Model

Review the available estimates for Medwellai Inc (OTC-MWAI), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.39

Estimated upside of 4.4% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.39

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Medwellai Inc (OTC-MWAI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Medwellai Inc (OTC-MWAI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.864 M

Current operating scale indicator.

Revenue Forecast

1.19 M

Forward revenue estimate.

EBITDA

-1.24 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Medwellai Inc (OTC-MWAI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Medwellai Inc (OTC-MWAI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Altman Z-Score

-475.6

Lower score that deserves closer risk review.

FCF / Net Income

18.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Medwellai Inc (OTC-MWAI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Medwellai Inc (OTC-MWAI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

September 25, 2026

Days to Earnings

3

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Medwellai Inc (OTC-MWAI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Medwellai Inc (OTC-MWAI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Medwellai Inc (OTC-MWAI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Medwellai Inc (OTC-MWAI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Medwellai Inc (OTC-MWAI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Medwellai Inc (OTC-MWAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Medwellai Inc (OTC-MWAI) Stock FAQ

Data-supported answers about Medwellai Inc (OTC-MWAI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.39
Estimated upside 4.4%
Valuation Rating
Undervalued
Estimated upside of 4.4%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Medwellai Inc (OTC-MWAI) is $0.39. This implies an estimated upside of 4.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 4.4% versus the current market price.

The current financial health read for Medwellai Inc (OTC-MWAI) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Medwellai Inc (OTC-MWAI) is September 25, 2026.

The latest available data indicates no current dividend yield for Medwellai Inc (OTC-MWAI).

The current market capitalization listed for Medwellai Inc is 2.419 M.

The current enterprise value listed for Medwellai Inc is 3.023 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Medwellai Inc is OTC-MWAI, and the stock is listed on OTC Markets.

Medwellai Inc (OTC-MWAI) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Medwellai Inc is 18.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Medwellai Inc is 51.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Software Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

MSFT NASDAQ Microsoft Corporation Fair Value Fair Market Cap 3,697.9 B
ORCL NYSE Oracle Corporation Fair Value Undervalued Market Cap 451.1 B
PLTR NASDAQ Palantir Technologies Inc Fair Value Overvalued Market Cap 444.5 B
PANW NASDAQ Palo Alto Networks Inc Fair Value Overvalued Market Cap 306.4 B
CRWD NASDAQ CrowdStrike Holdings Inc Fair Value Overvalued Market Cap 256.6 B
SAP NYSE SAP SE ADR Fair Value Fair Market Cap 240.9 B
CRM NYSE Salesforce Inc Fair Value Undervalued Market Cap 192 B
NOW NYSE ServiceNow Inc Fair Value Undervalued Market Cap 141.6 B
FTNT NASDAQ Fortinet Inc Fair Value Fair Market Cap 127.9 B
APP NASDAQ Applovin Corp Fair Value Undervalued Market Cap 110 B
ADBE NASDAQ Adobe Systems Incorporated Fair Value Bargain Market Cap 94.704 B
DDOG NASDAQ Datadog Inc Fair Value Overvalued Market Cap 88.862 B
CDNS NASDAQ Cadence Design Systems Inc Fair Value Fair Market Cap 83.43 B
SNPS NASDAQ Synopsys Inc Fair Value Fair Market Cap 78.425 B
INTU NASDAQ Intuit Inc Fair Value Bargain Market Cap 78.126 B
NBIS NASDAQ Nebius Group NV Fair Value Overvalued Market Cap 64.72 B
MSTR NASDAQ Strategy Inc Fair Value Fair Market Cap 64.292 B
TEAM NASDAQ Atlassian Corp Plc Fair Value Fair Market Cap 47.755 B
ADSK NASDAQ Autodesk Inc Fair Value Undervalued Market Cap 45.902 B
WDAY NASDAQ Workday Inc Fair Value Undervalued Market Cap 45.363 B